Nothing Special   »   [go: up one dir, main page]

UY26199A1 - Nuevos derivados de benceno, un procedimiento para su preparación y las composiciones farmacéuticas que los contienen - Google Patents

Nuevos derivados de benceno, un procedimiento para su preparación y las composiciones farmacéuticas que los contienen

Info

Publication number
UY26199A1
UY26199A1 UY26199A UY26199A UY26199A1 UY 26199 A1 UY26199 A1 UY 26199A1 UY 26199 A UY26199 A UY 26199A UY 26199 A UY26199 A UY 26199A UY 26199 A1 UY26199 A1 UY 26199A1
Authority
UY
Uruguay
Prior art keywords
procedure
contain
preparation
pharmaceutical compositions
benzene derivatives
Prior art date
Application number
UY26199A
Other languages
English (en)
Inventor
Robert Boigegrain
Bernard Bourrie
Martine Bourrie
Pierre Casellas
Jean Marc Herbert
Pierre Lair
Dino Nisato
Raymond Paul
Jean Claude Vernieres
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of UY26199A1 publication Critical patent/UY26199A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C211/34—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton
    • C07C211/35—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton containing only non-condensed rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C211/39—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton
    • C07C211/40—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing only non-condensed rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/58—Ring systems containing bridged rings containing three rings
    • C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74—Adamantanes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Transplantation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

La presente invención se refiere a compuestos de fórmula: (I). Estos compuestos se enlazan específicamente a los receptores sigma, en especial a los del sistema nervioso periférico.
UY26199A 1999-06-11 2000-06-09 Nuevos derivados de benceno, un procedimiento para su preparación y las composiciones farmacéuticas que los contienen UY26199A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9907396A FR2794742B1 (fr) 1999-06-11 1999-06-11 Nouveaux derives du benzene, un procede pour leur preparation et les compositions pharmaceutiques les contenant

Publications (1)

Publication Number Publication Date
UY26199A1 true UY26199A1 (es) 2001-01-31

Family

ID=9546664

Family Applications (1)

Application Number Title Priority Date Filing Date
UY26199A UY26199A1 (es) 1999-06-11 2000-06-09 Nuevos derivados de benceno, un procedimiento para su preparación y las composiciones farmacéuticas que los contienen

Country Status (33)

Country Link
US (1) US6482986B1 (es)
EP (1) EP1192122B1 (es)
JP (1) JP4711579B2 (es)
KR (1) KR100668581B1 (es)
CN (1) CN1210250C (es)
AR (1) AR033793A1 (es)
AT (1) ATE252542T1 (es)
AU (1) AU768420B2 (es)
BR (1) BR0011738A (es)
CA (1) CA2374631C (es)
CO (1) CO5180554A1 (es)
CZ (1) CZ299659B6 (es)
DE (1) DE60006113T2 (es)
DK (1) DK1192122T3 (es)
ES (1) ES2208345T3 (es)
FR (1) FR2794742B1 (es)
HK (1) HK1042891B (es)
HU (1) HU228683B1 (es)
IL (1) IL146545A0 (es)
MX (1) MXPA01012783A (es)
NO (1) NO327778B1 (es)
NZ (1) NZ515529A (es)
PL (1) PL196491B1 (es)
PT (1) PT1192122E (es)
RS (1) RS49998B (es)
RU (1) RU2248964C2 (es)
SI (1) SI1192122T1 (es)
SK (1) SK286390B6 (es)
TW (1) TWI279398B (es)
UA (1) UA71959C2 (es)
UY (1) UY26199A1 (es)
WO (1) WO2000076953A1 (es)
ZA (1) ZA200109486B (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10110750A1 (de) * 2001-03-07 2002-09-12 Bayer Ag Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften
GB2410947B (en) * 2004-02-11 2008-09-17 Cambridge Lab Ltd Pharmaceutical compounds
EP2583678A3 (en) 2004-06-24 2013-11-13 Novartis Vaccines and Diagnostics, Inc. Small molecule immunopotentiators and assays for their detection
EP1634598A1 (en) * 2004-09-07 2006-03-15 Laboratorios Del Dr. Esteve, S.A. Use of piperazine derivatives and analogues for the manufacture of a medicament for the prophylaxis and/or treatment of disorders of food ingestion
WO2006104221A1 (en) 2005-03-28 2006-10-05 Semiconductor Energy Laboratory Co., Ltd. Anthracene derivative, material for light emitting element, light emitting element, light emitting device, and electronic device
FR2887454B1 (fr) * 2005-06-28 2009-06-05 Sanofi Aventis Sa Combinaisons antitumorales contenant des derives du taxane et des sigma ligands
GB0514501D0 (en) * 2005-07-14 2005-08-24 Cambridge Lab Ireland Ltd Pharmaceutical compounds
GB0516168D0 (en) * 2005-08-05 2005-09-14 Cambridge Lab Ireland Ltd Pharmaceutical compounds
US7731377B2 (en) * 2006-03-21 2010-06-08 Semiconductor Energy Laboratory Co., Ltd. Backlight device and display device
WO2008026614A1 (en) * 2006-08-30 2008-03-06 Semiconductor Energy Laboratory Co., Ltd. Method for synthesizing anthracene derivative and anthracene derivative, light emitting element, light emitting device, electronic device
GR1005865B (el) * 2007-01-17 2008-04-07 Anavex Life Sciences Corp. Νεοι συνδετες των σιγμα υποδοχεων με αντι-αποπτωτικες και/η προ-αποπτωτικες ιδιοτητες επι των κυτταρικων βιοχημικων μηχανισμων, με νευρο-προστατευτικη, αντικαρκινικη, αντι-μεταστατικη και αντι- αντι-(χρονιο)φλεγμονικη δραση.
US7723722B2 (en) 2007-03-23 2010-05-25 Semiconductor Energy Laboratory Co., Ltd. Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device using anthracene derivative
FR2915994B1 (fr) * 2007-05-11 2009-07-03 Galderma Res & Dev Procede de synthese de l'acide (z)-3-[2-butoxy-3'-(3-heptyl-1-methyl-ureido)-biphenyl-4-yl] -2-methoxy-acrylique.
US20080286445A1 (en) * 2007-05-17 2008-11-20 Semiconductor Energy Laboratory Co., Ltd. Composition, and method of fabricating light-emitting element
GB0810857D0 (en) * 2008-06-13 2008-07-23 Cambridge Lab Ireland Ltd Pharmaceutical compounds
CN102089282A (zh) * 2008-07-08 2011-06-08 株式会社半导体能源研究所 咔唑衍生物、发光元件用材料、发光元件以及发光装置
US20110053866A1 (en) * 2008-08-12 2011-03-03 Biovail Laboratories International (Barbados) S.R.L. Pharmaceutical compositions
GB2462611A (en) * 2008-08-12 2010-02-17 Cambridge Lab Pharmaceutical composition comprising tetrabenazine
GB2463451A (en) * 2008-09-08 2010-03-17 Cambridge Lab 3, 11b cis-dihydrotetrabenazine compounds for use in the treatment of dementia
GB2463452A (en) * 2008-09-08 2010-03-17 Cambridge Lab Desmethyl derivatives of tetrabenazine and pharmaceutical compositions thereof
GB2463283A (en) * 2008-09-08 2010-03-10 Cambridge Lab 3,11b-cis-dihydrotetrabenazine for use in treating asthma
EP2330097B1 (en) * 2008-09-19 2013-01-23 Semiconductor Energy Laboratory Co, Ltd. Carbazole derivative and method for producing the same
WO2010059711A1 (en) * 2008-11-18 2010-05-27 Wisconsin Alumni Research Foundation Sigma-1 receptor ligands and methods of use
GR1006794B (el) * 2009-02-26 2010-06-04 Αλεξανδρος Βαμβακιδης Προσδετες των σιγμα υποδοχεων, αντι-αποπτωτικες και προ-αποπτωτικες ιδιοτητες επι των κυτταρικων μηχανισμων, και με πρωτοτυπη κυτταρο-προστατευτικη αλλα και αντικαρκινικη δραση
JP6492432B2 (ja) * 2013-07-09 2019-04-03 東ソー株式会社 アダマンチル基を有する環状アジン化合物、その製造方法、及びそれを構成成分とする有機電界発光素子
KR20170101128A (ko) 2016-02-26 2017-09-05 가부시키가이샤 한도오따이 에네루기 켄큐쇼 유기 화합물, 발광 소자, 발광 장치, 전자 기기, 및 조명 장치
MA53246A (fr) 2016-07-27 2021-07-28 Univ Case Western Reserve Composés et procédés pour favoriser la myélinisation
WO2019126759A1 (en) * 2017-12-22 2019-06-27 Convelo Therapeutics, Inc. Compounds and methods of promoting myelination
WO2019126702A1 (en) 2017-12-22 2019-06-27 Case Western Reserve University Compounds for promoting myelination
EP4392487A1 (en) * 2021-08-23 2024-07-03 Marquette University Synthesis and evaluation of novel (4-hydroxyphenyl) substituted carbocycles as potent and selective estrogen receptor beta agonists

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4104383A (en) * 1973-11-02 1978-08-01 C M Industries Derivatives of phenylpropenylamine
FR2641276B1 (fr) * 1988-12-30 1991-07-12 Sanofi Sa Derives du benzene, leur preparation et les compositions pharmaceutiques en contenant
ZA909902B (en) * 1989-12-21 1991-10-30 Himont Inc Graft copolymers of polyolefins and a method of producing same
EP0507863A4 (en) * 1989-12-28 1993-07-07 Virginia Commonwealth University Sigma receptor ligands and the use thereof
FR2663328B1 (fr) 1990-06-14 1994-08-05 Sanofi Sa Derives d'hexahydroazepines, un procede pour leur preparation et compositions pharmaceutiques les contenant.
CA2111957A1 (en) * 1991-06-27 1993-01-07 Richard A. Glennon Sigma receptor ligands and the use thereof
US5449639A (en) 1994-10-24 1995-09-12 Taiwan Semiconductor Manufacturing Company Ltd. Disposable metal anti-reflection coating process used together with metal dry/wet etch
FR2751645B1 (fr) * 1996-07-29 1998-12-24 Sanofi Sa Amines pour la fabrication de medicaments destines a empecher la proliferation de cellules tumorales

Also Published As

Publication number Publication date
US6482986B1 (en) 2002-11-19
YU87101A (sh) 2004-07-15
CN1355782A (zh) 2002-06-26
IL146545A0 (en) 2002-07-25
PL196491B1 (pl) 2008-01-31
JP2003502306A (ja) 2003-01-21
NO327778B1 (no) 2009-09-21
DE60006113D1 (de) 2003-11-27
SK286390B6 (sk) 2008-09-05
HK1042891A1 (en) 2002-08-30
CA2374631A1 (en) 2000-12-21
HU228683B1 (en) 2013-05-28
DK1192122T3 (da) 2004-03-01
RU2248964C2 (ru) 2005-03-27
NO20016038D0 (no) 2001-12-10
BR0011738A (pt) 2002-03-05
CN1210250C (zh) 2005-07-13
UA71959C2 (en) 2005-01-17
TWI279398B (en) 2007-04-21
JP4711579B2 (ja) 2011-06-29
RS49998B (sr) 2008-09-29
CZ20014443A3 (cs) 2002-05-15
MXPA01012783A (es) 2002-09-18
DE60006113T2 (de) 2004-07-15
FR2794742A1 (fr) 2000-12-15
SI1192122T1 (en) 2004-04-30
PT1192122E (pt) 2004-03-31
AU768420B2 (en) 2003-12-11
NZ515529A (en) 2004-01-30
PL352742A1 (en) 2003-09-08
CO5180554A1 (es) 2002-07-30
SK18062001A3 (sk) 2002-05-09
KR20020009632A (ko) 2002-02-01
AR033793A1 (es) 2004-01-07
WO2000076953A1 (fr) 2000-12-21
ES2208345T3 (es) 2004-06-16
CZ299659B6 (cs) 2008-10-08
EP1192122B1 (fr) 2003-10-22
HUP0201953A3 (en) 2006-03-28
CA2374631C (en) 2010-10-19
ATE252542T1 (de) 2003-11-15
AU5539600A (en) 2001-01-02
HUP0201953A2 (hu) 2002-12-28
EP1192122A1 (fr) 2002-04-03
HK1042891B (zh) 2004-04-08
KR100668581B1 (ko) 2007-01-17
FR2794742B1 (fr) 2005-06-03
ZA200109486B (en) 2002-11-18
NO20016038L (no) 2002-02-11

Similar Documents

Publication Publication Date Title
UY26199A1 (es) Nuevos derivados de benceno, un procedimiento para su preparación y las composiciones farmacéuticas que los contienen
ECSP034830A (es) Derivados sustituidos de la ciclohexano-1,4- diamina
ECSP066667A (es) Derivados de ciclohexano espirociclicos
HN2002000275A (es) Derivados de 1,8 naftiridina y su uso para el tratamiento de diabetes y trastornos relacionados
SV2002000249A (es) Derivados de tiazolilamida ref, lea 34082-sv
UY28931A1 (es) Derivados de pirrolotriazina utiles para tratar trastornos hiper-proliferativos y enfermedades asociadas con angiogenesis
ES2183180T3 (es) Nuevos derivados de guanidina, procedimientos para su preparacion y su uso como medicamento.
ES2178055T3 (es) Derivados aminicos substituidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
UY27852A1 (es) Difenilazatidinonas cationicamente sustituidas, procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso.
AR025052A1 (es) Derivados de 2-dialquilaminoalquilbifenilo sustituidos, procedimiento para su preparacion, medicamentos que contienen estos compuestos y el uso de estoscompuestos para la preparacion de medicamentos.
CU23415B7 (es) Derivados de 2,6- quinolinilo y 2,6- naftilo, procesos para su preparación y sus usos
SE9901077D0 (sv) Novel use
ES2187738T3 (es) Derivados de flavonas, su procedimiento de preparacion y los compuestos farmaceuticos que las contienen.
ECSP034531A (es) Derivados sustituidos de c-ciclohexilmetilamina
UY30356A1 (es) Derivados de 3-halo-n-(2.(4-fluorofenil)-4-oxobutil)-n-metil-5-(trifluorometil)benzamida y composiciones de los mismos.
AR002017A1 (es) Derivados de fenil-4-tiazoles substituidos, procedimiento para su preparacion, composiciones farmaceuticas que los contienen y derivados defenil-4-tiazoles substituidos empleados en dicho procedimiento.
SV1998000013A (es) Derivados de 5-aroilnaftaleno ref.-ran 4070\115
SV2006002121A (es) Prodrogas de estradiol ref. p-sv-78.325/msu
UY28911A1 (es) Profármacos de esteroides con acción androgénica
SV2006002122A (es) Prodrogas de estriol y estetrol ref. p-sv-78.343/msu
UY26507A1 (es) Bases de mannich de 1-naftol y 2-naftol sustituidos, procedimiento para su preparación, medicamentos que contienen estos compuestos, así como el uso de estos compuestos para la preparación de medicamentos
MX9303392A (es) Derivados de imidazo benzoxazin-1-ona substituidos y proceso para su preparacion.
UY26227A1 (es) Nuevos derivados de benceno, un procedimiento para su preparacion y las composiciones farmaceuticas que los contienen. ley 17164 art. 127
ECSP993230A (es) Antagonistas iii del receptor ccr-3
SV2005002076A (es) D-homo-17-cloro-16(17)eno esteroides ref.p-sv-78.100/msu

Legal Events

Date Code Title Description
110 Patent granted

Effective date: 20100806

VENC Patent expired

Effective date: 20200609